Assessing the Impact of Tissue Target Concentration Data on Uncertainty in In Vivo Target Coverage Predictions-Reference-Cited by-同舟云学术

Assessing the Impact of Tissue Target Concentration Data on Uncertainty in In Vivo Target Coverage Predictions

Published:2016-10 Issue:10 Volume:5 Page:565-574
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Tiwari A¹,Luo H²,Chen X¹,Singh P¹,Bhattacharya I³,Jasper P²,Tolsma JE²,Jones HM¹,Zutshi A,Abraham AK

Affiliation:

1. Department of PharmacokineticsDynamics, and Metabolism, Pfizer Worldwide R&DCambridge Massachusetts USA

2. RES GroupNeedham Massachusetts USA

3. Quantitative Clinical Sciences, PharmaTherapeutics R&D, Pfizer Inc.Cambridge Massachusetts USA;

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12126

Reference41 articles.

1. Protein therapeutics: a summary and pharmacological classification

2. New Horizons in Therapeutic Antibody Discovery

3. Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion

4. Biodistribution of monoclonal antibodies: scale‐up from mouse to human using a physiologically based pharmacokinetic model;Baxter L.T.;Cancer Res.,1995

5. How Modeling and Simulation Have Enhanced Decision Making in New Drug Development

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimally sufficient experimental design using identifiability analysis;npj Systems Biology and Applications;2024-01-06

2. Dose Finding in Oncology: What is Impeding Coming of Age?;Pharmaceutical Research;2022-04-26

3. Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo;Clinical Pharmacology & Therapeutics;2022-04-17

4. Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper;Drug Metabolism and Disposition;2022-02-11

5. A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs;Frontiers in Bioinformatics;2021-09-03